Cernostics Announces Three Patents Addressing the TissueCypher™ Technology Platform
Cernostics, a diagnostics company delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that the United States Patent and Trademark Office has issued two patents, US Patent 8,114,615 and US Patent...
Read more